These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 20108004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
    Kavanagh D, Goodship TH.
    Hematology Am Soc Hematol Educ Program; 2011; 2011():15-20. PubMed ID: 22160007
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L.
    Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.
    Ranghino A, Tognarelli G, Basso E, Messina M, Manzione AM, Daidola G, Segoloni GP.
    Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Does complement factor B have a role in the pathogenesis of atypical HUS?
    Kavanagh D, Kemp EJ, Richards A, Burgess RM, Mayland E, Goodship JA, Goodship TH.
    Mol Immunol; 2006 Mar; 43(7):856-9. PubMed ID: 16061287
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.
    Zhu Z, Chen H, Gill R, Wang J, Spitalewitz S, Gotlieb V.
    J Med Case Rep; 2016 Feb 24; 10():38. PubMed ID: 26911616
    [Abstract] [Full Text] [Related]

  • 35. [Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].
    Visconti L, Cernaro V, Ardissino G, Sgarbanti M, Ferrara D, Visconti G, Santoro D, Buemi M.
    G Ital Nefrol; 2017 Apr 24; 34(2):74-81. PubMed ID: 28682564
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S.
    Eur J Intern Med; 2013 Sep 24; 24(6):496-502. PubMed ID: 23743117
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.
    Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, Bigot S, Hue C, Satchell SC, Mathieson PW, Mousson C, Noel C, Sautes-Fridman C, Halbwachs-Mecarelli L, Atkinson JP, Lionet A, Fremeaux-Bacchi V.
    Blood; 2012 May 03; 119(18):4182-91. PubMed ID: 22246034
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.